[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"degenerative-spine-diseases\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:degenerative-spine-diseases":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100557970","minimal-invasive-transforaminal-lumbar-interbody-fusion-for-degenerative-lumbar-and-lumbosacral-spine-diseases-100557970",false,"NCT06545032","Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases","Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases : Clinical and Surgical Outcome","Inclusion Criteria:\n\n* Degenerative spondylolisthesis.\n* Degenerative unilateral disc herniations.\n* Recurrent disc herniation.\n\nExclusion Criteria:\n\n* Spondylolisthesis Grade III or IV.\n* Degenerative scoliosis .\n* Traumatic fracture spine.\n* Infections.\n* Neoplasms.\n* Debilitated patients .\n* Coagulation dysfunction.\n* Severe osteoporosis.",true,"ALL","18 Years","65 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.",[28],"Degenerative Spine Diseases","NOT_YET_RECRUITING","2024-08-06",{"date":32,"type":33},"2024-08-09","ACTUAL",{"date":35,"type":22},"2024-09",{"date":37,"type":22},"2025-10",{"name":39,"class":40},"Sohag University","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":16,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":23,"phases":52,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100548965","effect-of-topical-tranexamic-acid-on-postoperative-drainage-in-minimally-invasive-transforaminal-lumbar-interbody-fusion-mi-tlif-100548965","NCT06427850","Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF)","Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF): A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age 30-80 years old\n* Degenerative spine problems including spinal stenosis, disc degeneration, spondylolithesis that indicated for single level MI-TLIF\n\nExclusion Criteria:\n\n* Revision surgery\n* Patients who had high risk of complication from TXA\n* History of seizure, PE, DVT, thromboembolic episode\n* History of TXA allergy\n* Patients who had high risk for bleeding\n* U\u002FD : CKD stage more than IIIb (GFR\\\u003C 45 ml\u002Fmin\u002F1.73m2), hepatic disease, bleeding disorder\n* On anticoagulation drug or antiplatelet drug in 7 days before surgery\n* Abnormal coagulation profile (INR \\> 1.5) or CBC (platelet \\\u003C 100000)","30 Years","80 Years",{"count":51,"type":22},28,[25],"The randomized controlled study which compare the efficacy outcomes (reducing blood loss and drainage output in patients) in patients undergoing single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) and received topical tranexamic acid injection in the surgical site to those who received placebo injection.",[28,55],"Surgical Wound",[57,58,59],"Degenerative spine diseases","Surgical wound","Tranexamic acid (TXA)","2024-05-20",{"date":62,"type":33},"2024-05-24",{"date":64,"type":22},"2024-07-01",{"date":66,"type":22},"2026-12-01",{"name":68,"class":40},"Thanawan Longsuwan"]